Efficacy of Dasatinib in a CML Patient in Blast Crisis with F317L Mutation: A Case Report and Literature Review

The introduction of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML) has significantly increased survival rate and quality of life for patients with CML. Despite the high efficacy of imatinib, not all patients benefit from this treatment. Resistance to imatinib ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Morozova, E.V., Vlasova, Y.Y., Pryanishnikova, M.V., Lepik, K.V., Afanasyev, B.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674012/
https://www.ncbi.nlm.nih.gov/pubmed/26673003
http://dx.doi.org/10.4137/BMI.S22438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674012/
https://www.ncbi.nlm.nih.gov/pubmed/26673003
http://dx.doi.org/10.4137/BMI.S22438

Ejemplares similares